Biogen wins discovery for potential IP lawsuit against Sandoz

Clayton Utz 2021-12-22 8:47 pm By Bianca Hrovat | Sydney

Please login to bookmark

Swiss pharmaceutical company Biogen has won discovery of documents sent from Sandoz to the Therapeutic Goods Administration, as it weighs a third patent infringement lawsuit to protect its multiple sclerosis drug against generic reproductions.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au